Cambridge Research Biochemicals To Provide Monoclonal Antibody Production

Cambridge Research Biochemicals (CRB), a specialist in the custom production of polyclonal antibodies, is now expanding its antibody offering to include monoclonal antibody production via two new agreements with Babraham Bioscience Technologies (BBT) and Epitomics Inc. CRB and Cambridge-based BBT have formed an alliance that will enable CRB to market custom monoclonal antibody projects (via mouse/rat hybridomas) from BBT.

More: continued here

Filed under: Biology on September 30th, 2008